Clinical Trials Directory

Trials / Unknown

UnknownNCT00135616

Treatment of Female Stress Urinary Incontinence: Study Comparing Two Suburethral Slings, Retropubic Approach (TVT) and Trans-Obturator (TVT-O) Approach

Randomized Controlled Study Comparing Two Types of Suburethral Slings for the Surgical Treatment of Female Stress Incontinence : TVT and TVT-O.

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
180 (estimated)
Sponsor
Hopital Antoine Beclere · Academic / Other
Sex
Female
Age
18 Years – 95 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare efficacy and morbidity following the placement of two types of suburethral slings in women presenting with stress urinary incontinence: TVT and TVT-O.

Detailed description

Urinary stress incontinence (USI) is a frequent pathology in women. Surgical treatment is required in 30 to 50% of women presenting with USI. Several surgical techniques are currently available. At the present time, the placement of suburethral slings is one of the most efficient techniques. Furthermore, the placement of a suburethral sling is known to be associated with a low rate of complications. Currently, two approaches are available for the placement of a suburethral sling: retropubic approach (TVT) and trans-obturator approach (TVT-O). The efficacy of these two approaches seem equivalents. However, the morbidity related to these two techniques is probably different. In retrospective studies, the retropubic approach is associated with a higher rate of bladder perforation. On the other hand, the trans-obturator approach is supposed to be associated with a higher rate of post-operative pain. Thus, the purpose of this study is to compare efficacy and morbidity following the placement of two types of suburethral slings in women presenting with stress urinary incontinence: TVT and TVT-O.

Conditions

Interventions

TypeNameDescription
DEVICEsurgical placement of a suburethral sling tvt or tvt-o

Timeline

Start date
2005-03-01
Completion
2008-03-01
First posted
2005-08-26
Last updated
2007-04-30

Locations

14 sites across 1 country: France

Source: ClinicalTrials.gov record NCT00135616. Inclusion in this directory is not an endorsement.